These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8866918)

  • 1. Theophylline population pharmacokinetics from routine monitoring data in very premature infants with apnoea.
    Lee TC; Charles BG; Steer PA; Flenady VJ; Grant TC
    Br J Clin Pharmacol; 1996 Mar; 41(3):191-200. PubMed ID: 8866918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics of theophylline in very premature Japanese infants with apnoea.
    Fukuda T; Yukawa E; Kondo G; Maeda T; Shin-o T; Kondo Y; Imamura T; Irikura M; Irie T
    J Clin Pharm Ther; 2005 Dec; 30(6):591-6. PubMed ID: 16336292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetics of rectal theophylline in neonates.
    Karlsson MO; Thomson AH; McGovern EM; Chow P; Evans TJ; Kelman AW
    Ther Drug Monit; 1991 May; 13(3):195-200. PubMed ID: 1926271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The population pharmacokinetics of theophylline in neonates and young infants.
    Moore ES; Faix RG; Banagale RC; Grasela TH
    J Pharmacokinet Biopharm; 1989 Feb; 17(1):47-66. PubMed ID: 2715932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Population pharmacokinetic analysis of two theophylline formulations in premature neonates and infants with apnea].
    Suda Y; Hanada K; Tsuchiwata S; Saito M; Nakamura T; Ito Y; Ishikawa Y; Kushida K; Ogata H
    Yakugaku Zasshi; 2008 Apr; 128(4):635-40. PubMed ID: 18379181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of theophylline and caffeine after intravenous administration of aminophylline to premature neonates in Korea.
    Ahn HW; Shin WG; Park KJ; Suh OK; Choi JH
    Res Commun Mol Pathol Pharmacol; 1999; 105(1-2):105-13. PubMed ID: 10850374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theophylline pharmacokinetics in premature infants with apnea.
    Giacoia G; Jusko WJ; Menke J; Koup JR
    J Pediatr; 1976 Nov; 89(5):829-32. PubMed ID: 789845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caffeine citrate treatment for extremely premature infants with apnea: population pharmacokinetics, absolute bioavailability, and implications for therapeutic drug monitoring.
    Charles BG; Townsend SR; Steer PA; Flenady VJ; Gray PH; Shearman A
    Ther Drug Monit; 2008 Dec; 30(6):709-16. PubMed ID: 19057373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of theophylline in neonates as an aid to ventilator weaning.
    Capers CC; Ward ES; Murphy JE; Job ML; Land PA
    Ther Drug Monit; 1992 Dec; 14(6):471-4. PubMed ID: 1485368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacokinetics of theophylline in premature neonates during the first few days after birth.
    du Preez MJ; Botha JH; McFadyen ML; Holford NH
    Ther Drug Monit; 1999 Dec; 21(6):598-603. PubMed ID: 10604818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of theophylline in neonates.
    Simons FE; Rigatto H; Simons KJ
    Semin Perinatol; 1981 Oct; 5(4):337-45. PubMed ID: 7302609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetics of theophylline in premature Korean infants.
    Kim SE; Kim BH; Lee S; Sohn JA; Kim HS; Cho JY; Yoon SH; Jang IJ; Yu KS; Lim KS
    Ther Drug Monit; 2013 Jun; 35(3):338-44. PubMed ID: 23666573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting theophylline pharmacokinetics in premature infants with apnea.
    Hilligoss DM; Jusko WJ; Koup JR; Giacoia G
    Dev Pharmacol Ther; 1980; 1(1):6-15. PubMed ID: 7438966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hyponatremia and theophylline in very low birthweight premature infants].
    Sann L; Cottancin G; Bourgeois J; Bory C; Baltassat P; Bethenod M
    Arch Fr Pediatr; 1982; 39(7):419-22. PubMed ID: 7149887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics of intravenous amoxicillin in very low birth weight infants.
    Charles BG; Preechagoon Y; Lee TC; Steer PA; Flenady VJ; Debuse N
    J Pharm Sci; 1997 Nov; 86(11):1288-92. PubMed ID: 9383742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting the efficacy and safety of aminophylline in treatment of apnea of prematurity in neonatal intensive care unit.
    Ye C; Miao C; Yu L; Dong Z; Zhang J; Mao Y; Lu X; Lyu Q
    Pediatr Neonatol; 2019 Feb; 60(1):43-49. PubMed ID: 29673564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caffeine versus theophylline for apnea of prematurity: a randomised controlled trial.
    Skouroliakou M; Bacopoulou F; Markantonis SL
    J Paediatr Child Health; 2009 Oct; 45(10):587-92. PubMed ID: 19751376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reliability of salivary theophylline in monitoring the treatment for apnoea of prematurity.
    Chereches-Panta P; Nanulescu MV; Culea M; Palibroda N
    J Perinatol; 2007 Nov; 27(11):709-12. PubMed ID: 17717520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosage schedule for intravenous aminophylline in apnoea of prematurity, based on pharmacokinetic studies.
    Jones RA; Baillie E
    Arch Dis Child; 1979 Mar; 54(3):190-3. PubMed ID: 434904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics of intravenous caffeine in neonates with apnea of prematurity.
    Lee TC; Charles B; Steer P; Flenady V; Shearman A
    Clin Pharmacol Ther; 1997 Jun; 61(6):628-40. PubMed ID: 9209245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.